China National Pharmaceutical Group Corporation (Sinopharm)
Establishment time : 1998
website : www.sinopharm.com
Main Product : pharmaceuticals, medical devices, healthcare services
Company Profile
China National Pharmaceutical Group Corporation (Sinopharm) is a state-owned enterprise that operates in the pharmaceutical and healthcare industry. It is one of the largest pharmaceutical companies in China, with a wide range of products including pharmaceuticals, medical devices, and healthcare services. Sinopharm has a strong presence in the domestic market and is expanding globally through partnerships and acquisitions. The company is focused on providing high-quality and affordable healthcare products to consumers worldwide.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2003
website : www.lncd.com
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading provider of probiotics, enzymes, and feed additives for the agricultural industry. Founded in 2003, the company has grown to become a key player in both the domestic and international markets. With a focus on quality and innovation, Chengda Biotechnology continues to develop new products to meet the evolving needs of its customers.
Changchun Institute of Biological Products
Establishment time : 1958
website : http://www.cibp.cnic.cn/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products is a renowned manufacturer of vaccines and biological products, with a history dating back to 1958. The company has established itself as a leader in the industry, serving both the domestic Chinese market and international markets. With a large production capacity and a strong reputation for quality and innovation, Changchun Institute of Biological Products continues to be a key player in the global healthcare industry.
Chengdu Institute of Biological Products
Establishment time : 1969
website : http://www.cibp.cicams.ac.cn/
Main Product : vaccines, biological products
Company Profile
Chengdu Institute of Biological Products is a state-owned enterprise specializing in the research, development, and production of vaccines and biological products. With over 50 years of experience, the company has established itself as a trusted provider of high-quality medical products for both human and animal health.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1994
website : http://www.tyb.com.cn/en/
Main Product : Human insulin, Insulin API, Recombinant Human Insulin, Insulin analogs
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of insulin products. With a focus on innovation and quality, the company has established itself as a trusted provider of diabetes medications in both domestic and international markets.
Wuhan Institute of Biological Products
Establishment time : Wuhan Institute of Biological Products is a renowned biopharmaceutical company established in 1969.
website :
Main Product : With a large company size, Wuhan Institute of Biological Products serves both domestic and international markets.
Company Profile
For more information about Wuhan Institute of Biological Products, visit their official website at http://www.wibp.com.cn/.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1996.
website :
Main Product : With over 3,000 employees, Kangtai is one of the largest biopharmaceutical companies in China.
Company Profile
Shenzhen Kangtai Biological Products Co., Ltd. continues to expand its product portfolio and reach new markets worldwide.
